…
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. It offers specialty chemical products used as additives in diesel, jet, marine, fuel oil, and other fuels used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. It also provides technology-based solutions for customers' processes or products in personal care, home care, agrochemical, construction, mining, and other industrial markets. In addition, the company develops and markets chemical solutions for drilling, completion, production, drag reducing agents, and oil and gas applications. It serves large multinational companies, manufacturers of personal and home care products and global mining, agriculture and building products, and other industrial companies; national and multinational oil companies, fuel marketers and retailers, fuel terminals, marine lines, coating and plastics producers, and other heavy industrial end-users; and multinational public, independent exploration and production, and oilfield services companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Innospec Inc is a specialty chemicals company that develops, manufactures and supplies performance additives and chemical solutions for transportation fuels, oilfield services and consumer products globally. Long-term growth may be supported by demand for fuel-efficiency and emissions-control additives, recovery in oilfield spending and expansion in personal-care formulations, while a diversified product mix could appeal to investors seeking specialty-chemicals exposure.
Key risks include exposure to oil and industrial cyclicality, raw-material and energy cost volatility, regulatory compliance and environmental liabilities, competitive pricing pressure and foreign-exchange and execution risks.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 138.10M | 41.20M | 174.40M | 184.60M | 134.40M |
| Net income | 116.60M | 35.60M | 139.10M | 133.00M | 93.10M |
| Selling general administrative | 285.10M | 314.00M | 382.10M | 360.70M | 267.20M |
| Gross profit | 492.40M | 542.90M | 591.10M | 586.70M | 434.90M |
| Reconciled depreciation | 43.60M | 43.50M | 38.30M | 40.10M | 42.70M |
| Ebit | 138.10M | 181.10M | 174.40M | 187.30M | 132.10M |
| Ebitda | 187.40M | 224.60M | 213.70M | 225.80M | 176.80M |
| Depreciation and amortization | 49.30M | 43.50M | 39.30M | 38.50M | 44.70M |
| Non operating income net other | - | - | - | -1.60M | 3.80M |
| Operating income | 156.30M | 177.90M | 161.60M | 187.30M | 132.10M |
| Other operating expenses | 1621.70M | 1667.50M | 1787.20M | 1776.40M | 1353.10M |
| Interest expense | - | - | 2.30M | 1.10M | 1.50M |
| Tax provision | 21.50M | 5.60M | 47.50M | 51.60M | 41.30M |
| Net interest income | 9.20M | 9.30M | 0.80M | -1.10M | -1.50M |
| Income tax expense | 21.50M | 5.60M | 35.30M | 51.60M | 41.30M |
| Total revenue | 1778.00M | 1845.40M | 1948.80M | 1963.70M | 1483.40M |
| Total operating expenses | 336.10M | 365.00M | 429.50M | 399.40M | 304.60M |
| Cost of revenue | 1285.60M | 1302.50M | 1357.70M | 1377.00M | 1048.50M |
| Total other income expense net | -18.20M | -136.70M | 12.80M | -2.70M | 2.30M |
| Net income from continuing ops | 116.60M | 35.60M | 126.80M | 133.00M | 93.10M |
| Net income applicable to common shares | - | - | - | 133.00M | 93.10M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1832.40M | 1734.70M | 1707.40M | 1603.70M | 1570.90M |
| Intangible assets | 67.70M | 65.40M | 57.30M | 45.00M | 57.50M |
| Other current assets | 40.50M | 24.70M | 22.10M | 0.40M | 0.40M |
| Total liab | 499.50M | 518.60M | 557.80M | 563.30M | 537.90M |
| Total stockholder equity | 1326.10M | 1211.20M | 1147.10M | 1040.40M | 1033.00M |
| Deferred long term liab | - | - | - | 26.20M | 60.80M |
| Other current liab | 156.40M | 190.60M | 191.50M | 226.60M | 175.40M |
| Common stock | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M |
| Capital stock | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M |
| Retained earnings | 1099.20M | 1025.00M | 1028.20M | 924.20M | 822.90M |
| Other liab | - | - | - | 126.10M | 178.20M |
| Good will | 399.00M | 382.50M | 399.30M | 358.80M | 364.30M |
| Other assets | - | - | - | 61.10M | 171.20M |
| Cash | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M |
| Total current liabilities | 360.10M | 371.40M | 371.50M | 405.80M | 336.60M |
| Current deferred revenue | - | - | 2.80M | - | - |
| Net debt | -239.80M | -244.30M | -158.50M | -101.80M | -106.20M |
| Short term debt | 15.90M | 13.90M | 13.60M | 13.90M | 12.50M |
| Short long term debt total | 52.70M | 44.90M | 45.20M | 45.30M | 35.60M |
| Other stockholder equity | 261.30M | 276.90M | 266.70M | 261.10M | 256.70M |
| Property plant equipment | - | - | - | 220.90M | 249.80M |
| Total current assets | 1004.60M | 956.60M | 885.70M | 872.60M | 728.10M |
| Net tangible assets | - | - | - | 634.20M | 611.20M |
| Net receivables | 342.30M | 341.70M | 359.80M | 334.60M | 284.50M |
| Inventory | 329.30M | 301.00M | 300.10M | 373.10M | 277.60M |
| Accounts payable | 174.70M | 163.80M | 163.60M | 165.30M | 148.70M |
| Noncontrolling interest in consolidated entity | - | - | - | 2.40M | 0.60M |
| Accumulated other comprehensive income | -34.70M | -91.00M | -148.10M | -145.20M | -46.90M |
| Common stock total equity | - | - | - | 0.30M | 0.30M |
| Retained earnings total equity | - | - | - | 924.20M | 822.90M |
| Treasury stock | - | - | - | -95.40M | -90.60M |
| Non currrent assets other | 8.70M | 6.30M | 41.30M | 55.20M | 5.00M |
| Non current assets total | 827.80M | 778.10M | 821.70M | 731.10M | 842.80M |
| Capital lease obligations | 52.70M | 44.90M | 45.20M | 45.30M | 35.60M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -62.00M | -71.10M | -42.10M | -36.20M |
| Change to liabilities | - | - | - | 64.70M | 85.60M |
| Total cashflows from investing activities | -75.10M | -62.00M | -111.80M | -42.10M | -36.20M |
| Net borrowings | 0.00M | 0.00M | -2.30M | -0.10M | -0.60M |
| Total cash from financing activities | -63.90M | -35.30M | -39.00M | -33.70M | -20.00M |
| Change to operating activities | - | - | - | 3.20M | -45.20M |
| Net income | 116.60M | 35.60M | 139.10M | 133.00M | 93.10M |
| Change in cash | 3.30M | 85.50M | 56.60M | 5.30M | 36.50M |
| Begin period cash flow | 289.20M | 203.70M | 147.10M | 141.80M | 105.30M |
| End period cash flow | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M |
| Total cash from operating activities | 138.30M | 184.50M | 207.30M | 81.70M | 93.20M |
| Issuance of capital stock | 0.50M | 2.10M | 0.80M | 2.20M | 10.10M |
| Depreciation | 43.60M | 43.50M | 39.30M | 40.10M | 42.70M |
| Other cashflows from investing activities | -24.10M | 0.50M | 0.10M | -2.50M | 2.90M |
| Dividends paid | 42.40M | 38.80M | 35.10M | 31.70M | 28.80M |
| Change to inventory | -6.60M | -11.80M | 83.00M | -98.50M | -62.00M |
| Change to account receivables | 21.60M | 4.30M | -12.60M | -55.50M | -31.40M |
| Sale purchase of stock | -23.90M | -0.70M | -1.10M | -5.90M | -0.80M |
| Other cashflows from financing activities | 1.90M | 2.10M | -1.40M | 1.80M | 0.10M |
| Change to netincome | - | - | - | 1.20M | 5.50M |
| Capital expenditures | 50.30M | 41.40M | 62.10M | 42.30M | 39.10M |
| Change receivables | - | - | - | -55.50M | -70.30M |
| Cash flows other operating | - | - | - | -3.30M | -4.90M |
| Cash and cash equivalents changes | - | - | - | 5.90M | 37.00M |
| Change in working capital | -48.40M | -18.90M | 20.60M | -90.10M | -48.10M |
| Stock based compensation | 8.10M | 8.50M | 8.00M | 6.70M | 4.40M |
| Other non cash items | 28.60M | 155.10M | -3.30M | -2.50M | -5.30M |
| Free cash flow | 88.00M | 143.10M | 145.20M | 39.40M | 54.10M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IOSP Innospec Inc |
-0.92 1.16% |
78.21 | 18.78 | 14.37 | 1.23 | 1.69 | 1.12 | 10.79 |
| LIN Linde plc Ordinary Shares |
-5.98 1.15% |
515.25 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.75 1.77% |
41.68 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.00 0.00% |
211.18 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-4.96 1.42% |
344.05 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. It offers specialty chemical products used as additives in diesel, jet, marine, fuel oil, and other fuels used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. It also provides technology-based solutions for customers' processes or products in personal care, home care, agrochemical, construction, mining, and other industrial markets. In addition, the company develops and markets chemical solutions for drilling, completion, production, drag reducing agents, and oil and gas applications. It serves large multinational companies, manufacturers of personal and home care products and global mining, agriculture and building products, and other industrial companies; national and multinational oil companies, fuel marketers and retailers, fuel terminals, marine lines, coating and plastics producers, and other heavy industrial end-users; and multinational public, independent exploration and production, and oilfield services companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
8310 South Valley Highway, Englewood, CO, United States, 80112
303 792 5554
2450
| Name | Title | Year Born |
|---|---|---|
| Mr. Patrick S. Williams | Pres, CEO & Director | 1965 |
| Mr. Ian Philip Cleminson | Exec. VP & CFO | 1966 |
| Dr. Philip J. Boon | COO & Exec. VP | 1959 |
| Dr. Ian M. McRobbie | Chief Technology Officer and Sr. VP of Research & Technology | 1949 |
| Mr. David Bentley Jones | Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. | 1970 |
| Mr. Graeme Blair | Head of Group Fin. | 1983 |
| Dr. Corbin Barnes | Sr. VP of Corp. Devel. & Investor Relations | 1973 |
| Mr. Trey Griffin | Sr. VP of HR | 1966 |
| Mr. Thomas C. Entwistle | Pres of Oilfield Services - Americas | NA |
| Mr. Steven W. Williams | Exec. Director | 1956 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.